| 1.8 |
5.4 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 1.2 |
3.5 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 1.0 |
1.0 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.9 |
3.8 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.8 |
2.4 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.7 |
11.3 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.7 |
2.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.7 |
2.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.7 |
2.7 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.6 |
1.8 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.6 |
1.8 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.5 |
1.6 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.5 |
1.5 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.5 |
1.5 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.5 |
2.4 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.5 |
3.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
0.5 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.4 |
2.7 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.4 |
2.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 |
0.8 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.4 |
2.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.4 |
1.6 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.4 |
3.5 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.4 |
1.9 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.4 |
1.4 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.3 |
1.0 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
1.7 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
1.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
1.3 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.3 |
1.0 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.3 |
1.0 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.3 |
1.9 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
1.0 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.3 |
1.3 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.3 |
1.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
1.2 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.3 |
1.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.3 |
0.9 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.3 |
1.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.3 |
0.9 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.3 |
1.2 |
GO:1901204 |
positive regulation of guanylate cyclase activity(GO:0031284) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.3 |
0.3 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 |
5.9 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
1.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.3 |
1.8 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.3 |
0.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
0.9 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 |
1.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.3 |
0.9 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.3 |
0.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 |
1.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.3 |
1.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
1.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
2.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 |
0.5 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.3 |
1.0 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.2 |
0.7 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
0.5 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
1.0 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.2 |
1.7 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.2 |
0.9 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
0.9 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
1.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 |
0.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
1.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
0.9 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
1.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
0.8 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.8 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.2 |
1.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
1.8 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 |
0.6 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.2 |
0.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
0.8 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 |
3.2 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.2 |
1.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
2.5 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 |
5.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
0.8 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
0.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.2 |
0.8 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
0.8 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
0.8 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.2 |
0.8 |
GO:1902837 |
lysine transport(GO:0015819) amino acid import into cell(GO:1902837) |
| 0.2 |
1.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
0.7 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
0.5 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.7 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
1.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
0.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.2 |
1.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
1.0 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.2 |
0.5 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 |
1.0 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.2 |
0.3 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
0.6 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.2 |
0.5 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
0.2 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.2 |
0.2 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.2 |
0.6 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
1.2 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.2 |
2.0 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.4 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.1 |
0.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
0.4 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
1.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
| 0.1 |
1.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
2.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.4 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.1 |
0.4 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.1 |
0.4 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.5 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.7 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.1 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
1.0 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.4 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 |
0.5 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
1.0 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.1 |
0.2 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.1 |
0.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.4 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.1 |
0.2 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
2.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
1.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.9 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.7 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.3 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.1 |
0.2 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
0.1 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.6 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.6 |
GO:2000587 |
regulation of phospholipase A2 activity(GO:0032429) regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
1.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
1.2 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
2.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.7 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.0 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.5 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.1 |
0.3 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.1 |
0.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.0 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.4 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.2 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
1.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.4 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.2 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.1 |
0.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
0.2 |
GO:0046959 |
habituation(GO:0046959) |
| 0.1 |
0.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
1.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
2.0 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.5 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.4 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
2.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.9 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.4 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.7 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.3 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
2.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.6 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.3 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.7 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.1 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.7 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.4 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.1 |
1.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.7 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.1 |
0.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.3 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 |
0.3 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.6 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.1 |
0.5 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.3 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
1.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
0.2 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.1 |
0.3 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.5 |
GO:0001996 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.1 |
0.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
1.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.5 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.5 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
2.5 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
1.0 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.9 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.2 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.1 |
0.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
0.1 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
0.6 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.1 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.4 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.3 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.5 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
0.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.3 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
1.7 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.3 |
GO:0099623 |
regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
| 0.1 |
0.6 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.2 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.1 |
0.3 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
| 0.1 |
1.7 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 |
0.2 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.2 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 |
0.6 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.4 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
1.3 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 |
0.1 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.1 |
0.9 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.8 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.5 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.3 |
GO:0036394 |
amylase secretion(GO:0036394) |
| 0.1 |
1.6 |
GO:0086001 |
cardiac muscle cell action potential(GO:0086001) |
| 0.1 |
0.3 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.2 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
1.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
1.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.4 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.4 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.1 |
0.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.5 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.3 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 |
0.1 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.0 |
0.1 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
0.9 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.3 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.5 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.1 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.0 |
0.3 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
3.0 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.0 |
0.7 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.7 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
2.6 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
3.1 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
0.1 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.0 |
0.3 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.3 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.9 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.7 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
3.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.4 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.0 |
0.0 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.0 |
0.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.0 |
0.5 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.6 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 |
0.6 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.1 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.0 |
1.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.6 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.2 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.3 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.0 |
0.7 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.7 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.6 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.3 |
GO:0055074 |
calcium ion homeostasis(GO:0055074) |
| 0.0 |
0.6 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.6 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.1 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.5 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.6 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.0 |
0.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.0 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 0.0 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
2.5 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.0 |
0.2 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.0 |
0.4 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.1 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.0 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.9 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
3.1 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.0 |
0.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.8 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.0 |
0.8 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.2 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.0 |
0.3 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.7 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.0 |
0.5 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.8 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.2 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.1 |
GO:0060214 |
stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 0.0 |
0.2 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.2 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.2 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.2 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.7 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.3 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 |
0.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.6 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.2 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.2 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.3 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.0 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.0 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.0 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.3 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:1904707 |
cellular response to reactive nitrogen species(GO:1902170) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.2 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 |
0.8 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:0007173 |
epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 |
0.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.0 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.3 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 0.0 |
0.2 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.2 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
